Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Avalor Therapeutics
AddedMar 20, 2024
UpdatedJun 18, 2026
Avalor Therapeutics

Avalor Therapeutics

Pre-Seed

Kenmore-based medical organization, Avalor Therapeutics, pioneers precision medicine.

HQ
Kenmore, WA, US
Overview
Compare
Fundraising
Employees
News
Website

Founded in Kenmore, Washington, Avalor Therapeutics is dedicated to pioneering precision medicine. The company's core mission is to develop breakthrough medical treatments tailored to individual patient needs, enhancing the efficacy and safety of therapies. Avalor Therapeutics focuses on cutting-edge research and development to create innovative healthcare solutions that address unmet medical needs in various fields.

Avalor Therapeutics has garnered attention for its significant advancements in precision medicine, attracting notable investors and partnerships within the biotech industry. The organization has achieved key milestones in clinical trials and regulatory approvals, contributing to its reputation as a leader in personalized healthcare. Through its innovative approach, Avalor Therapeutics continues to make a substantial impact on patient outcomes and the broader medical community.

Avalor Therapeutics - Similar Companies

Avalo Therapeutics logo

Avalo Therapeutics

avalotx.com

Alphina Therapeutics logo

Alphina Therapeutics

Athenen Therapeutics logo

Athenen Therapeutics

Tisento Therapeutics logo

Tisento Therapeutics

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Advent Therapeutics logo

Advent Therapeutics

Valerion Therapeutics logo

Valerion Therapeutics

Path BioAnalytics logo

Path BioAnalytics

Emtherapro logo

Emtherapro

emtherapro.com

Precision Theranostics logo

Precision Theranostics

Avalyn Pharma logo

Avalyn Pharma

avalynpharma.com

Atossa Therapeutics logo

Atossa Therapeutics

Restora Medical logo

Restora Medical

Enavate Sciences logo

Enavate Sciences

Therapyx logo

Therapyx

therapyxinc.com

Avalor Therapeutics - Quick Facts

Who are Avalor Therapeutics' competitors?

Companies similar to Avalor Therapeutics include Avalo Therapeutics, Alphina Therapeutics, Athenen Therapeutics and Tisento Therapeutics.

Where is Avalor Therapeutics' headquarters located?

Avalor Therapeutics' headquarters is located in Kenmore, WA, US.

When was Avalor Therapeutics' last funding round?

Avalor Therapeutics' most recent funding round was for $335k (USD) in December 2023.

How much has Avalor Therapeutics raised to-date?

As of Dec 5, 2023, Avalor Therapeutics has raised a total of $335k (USD).

How many employees does Avalor Therapeutics have?

Avalor Therapeutics has 6 employees as of Feb 5, 2024.

Avalor Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Treatments
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research